(Press-News.org) CHAPEL HILL, North Carolina--Researchers have discovered a gene, OTUD7A, that impacts the development of Ewing sarcoma, a bone cancer that occurs mainly in children. They have also identified a compound that shows potential to block OTUD7A protein activity. The finding, by scientists at the University of North Carolina and the Lineberger Comprehensive Cancer Center, appeared online June 1, 2021, in Advanced Science.
About 250 children and young adults are diagnosed with Ewing sarcoma each year in the U.S. About half of those diagnosed will ultimately succumb to the disease, pointing to the need for better therapies.
"Our primary research focus targeted the EWS-FLI1 fusion protein found in about 85 percent of Ewing sarcoma patients," said UNC Lineberger's Pengda Liu, PhD, assistant professor of Biochemistry and Biophysics in the UNC School of Medicine and co-lead author. "This protein, made up of pieces of two other proteins, is unique to Ewing sarcoma and only produced in cancer cells, making it an excellent target for treatment."
Critical relationships between proteins contribute to the development of cancers such as Ewing sarcoma. So, it was a seminal discovery when the UNC researchers found that OTUD7A controls the cancer-causing fusion protein.
Armed with this knowledge, the scientists went on the hunt for small molecule compounds that could block OTUD7A's activity. Their collaborator, Atomwise Inc., used an artificial intelligence program known as AtomNet to screen four million small molecules to find ones that could fit into a pocket in OTUD7A. One compound they identified, 7Ai, showed a good ability to reduce tumor formation in mice that were grafted with human Ewing sarcoma cells. The compound did not appear to be toxic and was well-tolerated. Also, 7Ai did not kill normal cells that were tested in lab culture experiments.
"Treatment with 7Ai could provide a new targeted therapeutic option for patients who become resistant to chemotherapy. Developing an effective drug will require more lab work and then clinical studies, however," said Liu.
"By deeply exploring the key cellular processes that lead to cancer, unexpected potential therapeutic avenues can result," said co-author Ian Davis, MD, PhD, G. Denman Hammond Professor of Childhood Cancer and co-leader of the Cancer Genetics Program at UNC Lineberger. "Once the basic science validated our biological approaches, the application of computational virtual screening enabled us to quickly identify a lead molecule for further testing and validation."
The researchers are currently working with the UNC Eshelman School of Pharmacy to improve 7Ai's potency and specificity.
"I am particularly indebted to a UNC student with metastatic Ewing sarcoma who made it a priority to donate tissue that could be used for research," said Davis, who is also the associate division chief of pediatric hematology-oncology. "We're also appreciative of funding for our research through an NIH Beau Biden Pediatric Cancer Moonshot grant, which came about after the cancer-related death of President Biden's son."
INFORMATION:
Authors
In addition to Liu and Davis, the paper's other authors at UNC include Siyuan Su, PhD, Jianfeng Chen, PhD, Yao Jiang, Ying Wang, PhD, Tamara Vital, Jiaming Zhang, MD, Zhichuan Zhu, PhD, Alex W. Prevatte, Natalie K. Barker, and Laura E. Herring, PhD. Christian Laggner and Kong T. Nguyen are at Atomwise Inc., San Francisco.
"SWOG always brings an impressive portfolio of work to the ASCO annual meeting," said SWOG Chair Charles D. Blanke, MD, "and this year I'm particularly excited about the research our investigators are presenting because it includes results that are likely to be practice-changing."
Investigators will present 12 abstracts from SWOG-led or co-led studies and 11 abstracts from studies led by other groups within the National Clinical Trials Network (NCTN).
Results from S1216 will be presented orally by study chair Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah. S1216 compared androgen deprivation therapy (ADT) combined with TAK-700 to the standard ...
Quantum computing and quantum sensing have the potential to be vastly more powerful than their classical counterparts. Not only could a fully realized quantum computer take just seconds to solve equations that would take a classical computer thousands of years, but it could have incalculable impacts on areas ranging from biomedical imaging to autonomous driving.
However, the technology isn't quite there yet.
In fact, despite widespread theories about the far-reaching impact of quantum technologies, very few researchers have been able to demonstrate, using the technology available now, that quantum methods have an advantage over their classical counterparts.
In a paper published on June 1 in the journal Physical Review X, University of Arizona researchers experimentally ...
Irvine, CA - June 1, 2021 - A new study analyzing the association between an individual's genetics (genotype) and their observable characteristics resulting from the interaction of genetics and the environment (phenotype), contributes new knowledge to the understanding of human complex traits and diseases.
The study titled, "An atlas of alternative polyadenylation quantitative trait loci (3?aQTLs) contributing to complex trait and disease heritability," was recently published in Nature Genetics. Led by University of California, Irvine professor of ...
Over 50% of adults surveyed across six different countries report experiencing weight stigma, and those who engage in self-stigma and self-blame for their weight are more likely to avoid healthcare, obtain less frequent checkups, and perceive less respect from doctors, according to two new studies from the UConn Rudd Center for Food Policy and Obesity. These studies, which compared experiences of adults in Australia, Canada, France, Germany, the UK, and the US are the first multi-national studies to examine the link between weight stigma and negative ...
Plasmodium vivax malaria is a mosquito-borne illness that causes significant morbidity. However, the household and healthcare provider costs of the disease are unknown. A new study published in the open-access journal PLOS Medicine by Dr Angela Devine at Menzies School of Health Research in Australia, and colleagues estimate the global economic burden of P. vivax for the first time using country-level data.
Researchers first estimated household and healthcare provider P. vivax costs, then collated and combined these data with national case estimates for 44 endemic countries in 2017. The resulting global cost estimate was US$359 million.
The authors wanted to explore how these cost estimates might change with widespread access to radical cure. Radical ...
Observational studies have suggested that increased vitamin D levels may protect against COVID-19. However, these studies were inconclusive and possibly subject to confounding. A study published in PLOS Medicine by Guillaume Butler-Laporte and Tomoko Nakanishi at McGill University in Quebec, Canada, and colleagues suggests that genetic evidence does not support vitamin D as a protective measure against COVID-19.
The ability of vitamin D to protect against severe COVID-19 illness is of great interest to public health experts, but has limited supporting evidence. To assess the relationship between vitamin D levels and COVID-19 susceptibility ...
A nationwide study in Sweden estimates the elevated risk of advanced or fatal prostate cancer among relatives of men with the disease, providing new data that could help refine guidelines for the age at which screening should begin. Mahdi Fallah and Elham Kharazmi of the German Cancer Research Center (DKFZ) in Heidelberg, Germany, and colleagues present these new findings in the open-access journal PLOS Medicine.
Clinical guidelines for the age to start prostate cancer screening aim to ensure that the benefits of identifying the disease early ...
The malaria parasite Plasmodium vivax may accumulate in the spleen soon after infection to a greater extent than its better-known relative P. falciparum, according to new research published by John Woodford of the University of Queensland, Brisbane, Australia and colleagues in the open access journal PLOS Medicine.
Managing and treating P. vivax and P. falciparum infections calls for investigation of their different pathways of infection, and our limited understanding of disease pathology has generally relied on indirect and imprecise approaches. Woodford and colleagues studied 7 healthy participants who were infected under controlled conditions with either P. vivax or P. falciparum. They underwent a Positron Emission Tomography (PET) ...
Many organisms in need of conservation are still unknown or lumped in with similar species, which potentially interferes with conservation efforts. In a new study published June 1 in the Open Access journal PLOS Biology, Jane Melville of Museums Victoria, and her colleagues present a new "return-on-investment" approach to best direct efforts to identify new species before they are lost.
Humans have had a profoundly destructive impact on global biodiversity. However, this loss of biodiversity may be even greater than scientists have realized, due to the unknown number of undocumented species. Before a species and its habitat can be preserved, though, it must first ...
Stigma and high care needs can present barriers to the provision of high-quality primary care for people with opioid use disorder (OUD) and those prescribed opioids for chronic pain. A study published in PLOS Medicine by Tara Gomes at the Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Canada and colleagues suggests that people treated for an opioid use disorder were less likely to find a new primary care provider (PCP) within one year of termination of enrolment with the previous physician.
People with substance use disorders often have complex medical needs, requiring ...
